The estimated Net Worth of John Cipriano is at least $1.82 Million dollars as of 22 April 2021. Mr. Cipriano owns over 10,000 units of Cel-Sci stock worth over $74,467 and over the last 21 years he sold CVM stock worth over $539,975. In addition, he makes $1,200,690 as Senior Vice President - Regulatory Affairs at Cel-Sci.
Sign up
Mr. Cipriano CVM stock SEC Form 4 insiders trading
John has made over 8 trades of the Cel-Sci stock since 2004, according to the Form 4 filled with the SEC. Most recently he sold 10,000 units of CVM stock worth $243,800 on 22 April 2021.
The largest trade he's ever made was selling 17,109 units of Cel-Sci stock on 16 August 2017 worth over $43,115. On average, John trades about 1,422 units every 122 days since 2004. As of 22 April 2021 he still owns at least 63,108 units of Cel-Sci stock.
You can see the complete history of Mr. Cipriano stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Cipriano biography
John Cipriano serves as Senior Vice President - Regulatory Affairs of the Company. Mr. Cipriano brings to CEL-SCI over 30 years of experience with both biotech and pharmaceutical companies. In addition, he held positions at the United States Food and Drug Administration (FDA) as Deputy Director, Division of Biologics Investigational New Drugs, Office of Biologics Research and Review and was the Deputy Director, IND Branch, Division of Biologics Evaluation, Office of Biologics. Mr. Cipriano completed his B.S. in Pharmacy from the Massachusetts College of Pharmacy in Boston, Massachusetts and his M.S. in Pharmaceutical Chemistry from Purdue University in West Lafayette, Indiana.
What is the salary of John Cipriano?
As the Senior Vice President - Regulatory Affairs of Cel-Sci, the total compensation of John Cipriano at Cel-Sci is $1,200,690. There are 4 executives at Cel-Sci getting paid more, with Geert Kersten having the highest compensation of $4,546,360.
How old is John Cipriano?
John Cipriano is 78, he's been the Senior Vice President - Regulatory Affairs of Cel-Sci since 2009. There are 3 older and 10 younger executives at Cel-Sci. The oldest executive at Cel-Sci Corp. is Dr. Daniel H. Zimmerman Ph.D., 80, who is the Sr. VP of Research & Cellular Immunology.
What's John Cipriano's mailing address?
John's mailing address filed with the SEC is 8229 BOONE BLVD, SUITE 802, VIENNA, VA, 22182.
Insiders trading at Cel-Sci
Over the last 21 years, insiders at Cel-Sci have traded over $3,069,559 worth of Cel-Sci stock and bought 1,693,350 units worth $1,328,136 . The most active insiders traders include Clara Maximilian De, Geert R Kersten, and Eyal Talor. On average, Cel-Sci executives and independent directors trade stock every 50 days with the average trade being worth of $42,938. The most recent stock trade was executed by Robert Eugene Watson on 8 May 2024, trading 20,000 units of CVM stock currently worth $27,800.
What does Cel-Sci do?
cel-sci corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. the company's lead investigational immunotherapy is multikine, which is under phase iii clinical trial for the treatment of head and neck cancer. its ligand epitope antigen presentation system (leaps), a pre-clinical patented t-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. the company also develops leaps-h1n1-dc; cel-2000 and cel-4000 are product candidates for the treatment of rheumatoid arthritis; and leaps cov-19, a product candidate to treat covid-19 coronavirus. cel-sci corporation has a collaboration agreement with the university of georgia's center for vaccines and immunology to develop leaps covid-19 immunotherapy. the company was founded in 1983 and is headquartered in vienna, virginia.
What does Cel-Sci's logo look like?
Complete history of Mr. Cipriano stock trades at Cel-Sci
Cel-Sci executives and stock owners
Cel-Sci executives and other stock owners filed with the SEC include:
-
Geert Kersten,
Chief Executive Officer, Treasurer, Director -
Patricia Prichep,
Senior Vice President - Operations, Corporate Secretary -
Eyal Talor,
Chief Scientific Officer -
Daniel Zimmerman,
Senior Vice President - Research, Cellular Immunology -
John Cipriano,
Senior Vice President - Regulatory Affairs -
Peter Young,
Independent Director -
Robert Watson,
Independent Director -
Bruno Baillavoine,
Independent Director -
Geert R. Kersten,
CEO, Principal Accounting & Financial Officer, Treasurer and Director -
Geert R. Kersten Esq.,
Chief Exec. & Financial Officer, Treasurer and Director -
Dr. Eyal Talor Ph.D.,
Chief Scientific Officer -
Patricia B. Prichep,
Sr. VP of Operations & Corp. Sec. -
Dr. Daniel H. Zimmerman Ph.D.,
Sr. VP of Research & Cellular Immunology -
John Cipriano,
Sr. VP of Regulatory Affairs -
Clara Maximilian De,
President -
Alexander G Esterhazy,
Director -
C Richard Kinsolving,
Director -
Gail K Naughton,
Director